Post-Capillary Pulmonary Hypertension: Clinical Review

被引:0
|
作者
Riley, Joshua M. [1 ]
Fradin, James J. [2 ]
Russ, Douglas H. [1 ]
Warner, Eric D. [1 ]
Brailovsky, Yevgeniy [3 ]
Rajapreyar, Indranee [3 ]
机构
[1] Thomas Jefferson Univ Hosp, Dept Med, Philadelphia, PA 19147 USA
[2] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA 19147 USA
[3] Thomas Jefferson Univ Hosp, Jefferson Heart Inst, Philadelphia, PA 19147 USA
关键词
pulmonary hypertension; post-capillary; heart failure; advanced heart failure; HFrEF; PRESERVED EJECTION FRACTION; LEFT-VENTRICULAR DYSFUNCTION; HOSPITALIZED HEART-FAILURE; VASCULAR-RESISTANCE; WEDGE PRESSURE; DIASTOLIC DYSFUNCTION; EXERCISE CAPACITY; PROGNOSTIC VALUE; OUTCOMES; MORTALITY;
D O I
10.3390/jcm13020625
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pulmonary hypertension (PH) caused by left heart disease, also known as post-capillary PH, is the most common etiology of PH. Left heart disease due to systolic dysfunction or heart failure with preserved ejection fraction, valvular heart disease, and left atrial myopathy due to atrial fibrillation are causes of post-capillary PH. Elevated left-sided filling pressures cause pulmonary venous congestion due to backward transmission of pressures and post-capillary PH. In advanced left-sided heart disease or valvular heart disease, chronic uncontrolled venous congestion may lead to remodeling of the pulmonary arterial system, causing combined pre-capillary and post-capillary PH. The hemodynamic definition of post-capillary PH includes a mean pulmonary arterial pressure > 20 mmHg, pulmonary vascular resistance < 3 Wood units, and pulmonary capillary wedge pressure > 15 mmHg. Echocardiography is important in the identification and management of the underlying cause of post-capillary PH. Management of post-capillary PH is focused on the treatment of the underlying condition. Strategies are geared towards pharmacotherapy and guideline-directed medical therapy for heart failure, surgical or percutaneous management of valvular disorders, and control of modifiable risk factors and comorbid conditions. Referral to centers with advanced heart and pulmonary teams has shown to improve morbidity and mortality. There is emerging interest in the use of targeted agents classically used in pulmonary arterial hypertension, but current data remain limited and conflicting. This review aims to serve as a comprehensive summary of postcapillary PH and its etiologies, pathophysiology, diagnosis, and management, particularly as it pertains to advanced heart failure.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Arterial-ventricular and interventricular interaction in isolated post-capillary and combined pulmonary hypertension in severe mitral stenosis
    Ashwin Venkateshvaran
    Srikanth Sola
    Satish Chandra Govind
    Pravat Kumar Dash
    Sagar Vyavahare
    Lars H. Lund
    Bé la Merkely
    Anikó Ilona Nagy
    Aristomenis Manouras
    European Journal of Applied Physiology, 2016, 116 : 1545 - 1554
  • [32] The β3-adrenoreceptor agonist mirabegron for the treatment of combined pre- and post-capillary pulmonary hypertension: new pathway or dead end?
    Maeder, Micha T.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 (03) : 386 - 388
  • [33] A novel echo-score for evaluating the pre-test probability of pre-capillary versus post-capillary pulmonary hypertension
    D'Alto, Michele
    Romeo, Emanuele
    Argiento, Paola
    Correra, Anna
    Sarubbi, Berardo
    Pignatiello, Maria
    Caronna, Antonietta
    Grimaldi, Nicola
    Calabro, Raffaele
    Russo, Maria Giovanna
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [34] mRNA sequencing of educated platelets generates a diagnostic biomarker for discrimination between pre- and post-capillary pulmonary hypertension
    Arkani, Mohammad
    Jansen, Samara
    Veld, Sjors In'T
    Smits, Josien
    Post, Edward
    Zwaan, Kenn
    Ramaker, Jip
    De Man, Frances S.
    Noordegraaf, Anton Vonk
    Best, Myron
    Wurdinger, Thomas
    Bogaard, Harm-Jan
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [35] The transpulmonary ratio of endothelin 1 is elevated in patients with preserved left ventricular ejection fraction and combined pre- and post-capillary pulmonary hypertension
    Meoli, David F.
    Su, Yan Ru
    Brittain, Evan L.
    Robbins, Ivan M.
    Hemnes, Anna R.
    Monahan, Ken
    PULMONARY CIRCULATION, 2018, 8 (01)
  • [36] The future of group 2 pulmonary hypertension: Exploring clinical trials and therapeutic targets
    Awada, Charifa
    Boucherat, Olivier
    Provencher, Steeve
    Bonnet, Sebastien
    Potus, Francois
    VASCULAR PHARMACOLOGY, 2023, 151
  • [37] Intratracheal Gene Delivery of SERCA2a Ameliorates Chronic Post-Capillary Pulmonary Hypertension A Large Animal Model
    Aguero, Jaume
    Ishikawa, Kiyotake
    Hadri, Lahouaria
    Santos-Gallego, Carlos G.
    Fish, Kenneth M.
    Kohlbrenner, Erik
    Hammoudi, Nadjib
    Kho, Changwon
    Lee, Ahyoung
    Ibanez, Borja
    Garcia-Alvarez, Ana
    Zsebo, Krisztina
    Maron, Bradley A.
    Plataki, Maria
    Fuster, Valentin
    Leopold, Jane A.
    Hajjar, Roger J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (17) : 2032 - 2046
  • [38] Is Pulmonary Capillary Wedge Pressure a Reliable Indicator of Postcapillary Pulmonary Hypertension?
    Aslanger, Emre
    Akaslan, Dursun
    Atas, Halil
    Yildirimturk, Ozlem
    Oz, Melih
    Kocakaya, Derya
    Yildizeli, Bedrettin
    Mutlu, Bulent
    AMERICAN JOURNAL OF CARDIOLOGY, 2024, 211 : 307 - 315
  • [39] Role of 3D echocardiography-determined atrial volumes in distinguishing between pre-capillary and post-capillary pulmonary hypertension
    Jenei, Csaba
    Kadar, Rebeka
    Balogh, Laszlo
    Borbely, Attila
    Gyory, Ferenc
    Peter, Andrea
    Darago, Andrea
    Csanadi, Zoltan
    ESC HEART FAILURE, 2021, 8 (05): : 3975 - 3983
  • [40] Pulmonary Hypertension: A Contemporary Review
    Johnson, Shelsey
    Sommer, Natascha
    Cox-Flaherty, Katherine
    Weissmann, Norbert
    Ventetuolo, Corey E.
    Maron, Bradley A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 208 (05) : 528 - 548